RNWFX
Price
$77.72
Change
+$0.12 (+0.15%)
Updated
Dec 20 closing price
SBHEX
Price
$9.59
Change
+$0.01 (+0.10%)
Updated
Dec 20 closing price
Ad is loading...

RNWFX vs SBHEX

Header iconRNWFX vs SBHEX Comparison
Open Charts RNWFX vs SBHEXBanner chart's image
American Funds New World R5
Price$77.72
Change+$0.12 (+0.15%)
VolumeN/A
CapitalizationN/A
Segall Bryant & Hamill Em Mkts Retl
Price$9.59
Change+$0.01 (+0.10%)
VolumeN/A
CapitalizationN/A
RNWFX vs SBHEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RNWFX vs. SBHEX commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNWFX is a Buy and SBHEX is a Hold.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 62.2B vs. SBHEX (67.5M). SBHEX pays higher dividends than RNWFX: SBHEX (5.11) vs RNWFX (1.51). RNWFX was incepted earlier than SBHEX: RNWFX (23 years) vs SBHEX (10 years). SBHEX is a more actively managed with annual turnover of: 85.00 vs. RNWFX (32.00). RNWFX has a lower initial minimum investment than SBHEX: RNWFX (250) vs SBHEX (2500). SBHEX annual gain was more profitable for investors over the last year : 16.79 vs. RNWFX (5.86). SBHEX return over 5 years is better than : 29.68 vs. RNWFX (14.39).
RNWFXSBHEXRNWFX / SBHEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD4.54914.43932%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets62.2B67.5M92,148%
Annual Yield % from dividends1.515.1129%
Returns for 1 year5.8616.7935%
Returns for 3 years-5.1017.21-30%
Returns for 5 years14.3929.6849%
Returns for 10 years42.6757.4674%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTRS12.520.39
+3.22%
Viatris
TEO11.890.14
+1.19%
Telecom Argentina SA
DX12.570.14
+1.13%
Dynex Capital
INTT7.680.04
+0.52%
inTEST Corp
VIRX0.21N/A
-1.87%
Viracta Therapeutics